2Linkeschova R, Raoul M, Bott U, et al. Less severe hypoglycemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years [ J]. Diabetes Med ,2002,9(19) :746 - 751.
